Introduction
Neurite growth is a critical step for successful nerve regeneration after injury.
Extracellular factors surrounding the ends of injured axons were previously considered the major reasons affecting axonal growth (Filbin, 2003; Martin E, 2004; Yiu and He, 2006) . However, recent evidence indicates that the activation of intrinsic molecules also play an important role (Abe and Cavalli, 2008; Chen et al., 2007; Liu et al., 2011; Sun and He, 2010) . Several protein kinases, transcription factors, and growth-associated molecules have been shown to be intrinsic molecules that positively regulate axon growth (Chen et al., 2007; Gao et al., 2004; Lorber et al., 2009; MacGillavry et al., 2009; Moore et al., 2009; Seijffers et al., 2007) . Downregulation or low activity of these positive molecules causes reduced axonal growth and failure of nerve regeneration. However, intrinsic molecules that negatively regulate axonal growth are also considered important when the cell is unable to eliminate or even activate these molecules following nerve injury (Abe and Cavalli, 2008; Liu et al., 2011) . The transforming growth factor-β (TGF-β)/Smad signaling pathway inhibits axon growth (de la Torre-Ubieta and Bonni, 2011). Knocking down Smad2 or blocking the TGF-β/Smad signaling pathway with SB431542 or specific antibodies enables axons to override myelin inhibition and promotes functional recovery after spinal cord injury (He and Wang, 2006; Kohta et al., 2009; Stegmuller et al., 2008) .
Protein phosphatase 1 (PP1) is a eukaryotic protein serine/threonine phosphatase that is important in regulating neuronal morphology. Inactivation of PP1 by control of the regulatory subunit GADD34, PP1 is targeted to the type I transforming growth factor-β receptor (TβRI) and inactivates this Ser/Thr kinase receptor through dephosphorylating the juxta-membrane region (Shi et al., 2004 ).
IPP5, a newly identified regulatory subunit of PP1, belongs to the protein phosphatase 1 regulatory subunit 1 (PPP1R1) family, which has a highly conserved PP1 binding motif and a PP1 inhibiting motif. IPP5 inhibits the enzymatic activity of PP1 after being phosphorylated within its PP1 inhibiting motif at Thr 34 (Wang et al., 2008) . IPP5 promotes tumor cell cycle progression by accelerating the G1-S transition in a PP1-dependent manner (Wang et al., 2008) , inhibits anchorage-dependent growth and induces apoptosis of HeLa cells (Zeng et al., 2009) . However, the function of IPP5 in the nervous system has not been investigated. In the present study, IPP5 was
shown to be selectively expressed in the dorsal root ganglion (DRG) neurons of rats.
The DRG contains pseudounipolar sensory neurons that extend their peripheral terminals to peripheral tissues and their central terminals to the dorsal horn of the spinal cord to convey somatic sensory signals. Generally, DRG neurons cultured in vitro generate multiple neurites, which reflects the growth ability of these sensory neurons. We found that IPP5 inhibits neurite growth in cultured DRG neurons by inhibiting PP1 activity and maintaining TGF-β/Smad signaling. Blocking TGF-β/Smad signaling and PP1 function impaired the IPP5-induced inhibition of neurite growth. Thus, IPP5 is a novel intrinsic molecule that negatively regulates neurite growth in primary sensory neurons.
Results

IPP5 is selectively expressed in primary sensory neurons and downregulated after sciatic nerve axotomy
We searched the Unigene library of the National Center for Biotechnology Information (NCBI) to identify genes that are highly expressed in the DRG but are expressed at relatively low levels in other tissues. In this process, we identified IPP5.
By applying the reverse transcription polymerase chain reaction (PCR), we further confirmed that IPP5 was highly expressed in the DRG of rats but showed no
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detectable expression in other regions of the central nervous system, including the cortex, cerebellum, hypothalamus, hippocampus, medulla oblongata, pituitary gland and spinal cord (Fig. 1A) . Amino acid sequence alignment showed that IPP5 belonged to the PPP1R1 family, possessing a highly conserved PP1 docking motif " 8 KIQF 12 "
and a PP1 inhibiting motif " 31 RRPTPA 36 " (Fig. 1B) . We also analyzed the expression patterns of the other two members of the PPP1R1 family, inhibitor-1 and dopamine and cAMP-regulated phosphoprotein Mr 32 kDa (DARPP-32), which exhibited universal distributions in nervous system but low expression in the DRG of rats (Fig.   1A ).
To further explore the cell-type characterization of IPP5 in the DRG, we µm) with myelinated Aβ-fibers (Fig. 1C) . Consistently, double immunofluorescence staining in the dorsal horn of the spinal cord showed abundant IPP5-positive nerve fibers in laminae I-II and a few IPP5-positive nerve fibers in laminae III-IV (Fig. 1D ).
Most IPP5-positive nerve fibers were located in the inner laminae II, an area that exhibited IB4 binding (Fig. 1D) and gradually recovered to approximately 60% at post-nerve injury Day 14 (Fig. 1F ).
Thus, IPP5 is remarkably downregulated in DRG neurons after nerve injury and may serve as a neurite growth inhibitory molecule in primary sensory neurons.
Knocking down IPP5 promotes neurite growth in cultured primary sensory neurons
To examine the effect of IPP5 on neurite growth, we used a plasmid-based method of IPP5 shRNA ( Fig. 2A) to knock down endogenous IPP5 in rat primary sensory neurons. We electroporated scrambled or IPP5 shRNA plasmids into dissociated DRG neurons. The IPP5 protein levels were significantly decreased two days after transfection with IPP5 shRNA plasmids (Fig. 2B) , indicating that the construct efficiently interfered with endogenous IPP5 expression. We also constructed a shRNA-resistant (R) IPP5 (IPP5 R , Fig. 2A ) that was not silenced by IPP5 shRNA.
The expression level of IPP5 was unchanged after coexpressing the IPP5 shRNA plasmid with IPP5 R in ND7-23 cells (Fig. 2C ), indicating that IPP5 R is not targeted by IPP5 shRNA. In cultured DRG neurons, the effect of IPP5 shRNA on expression of endogenous IPP5 could be rescued by IPP5 R as well (Fig. 2B ).
Importantly, two days after knocking down IPP5 in cultured DRG neurons, the length of the longest neurite was increased by approximately 24% (Fig. 2D, E) , the total neurite length was increased by approximately 35% (Fig. 2D, F) , and the number Journal of Cell Science Accepted manuscript of neurite ends was increased by approximately 18% (Fig. 2D, G) . The cumulative frequency curves of all measures were significantly right-shifted in DRG neurons transfected with IPP5 shRNA (Fig. 2E-G) . Coexpression of untargeted IPP5 R corrected the length of the longest neurite, the total neurite length and the number of neurite ends, which were increased by IPP5 shRNA (Fig. 2D-G) , indicating that the phenotype caused by silencing IPP5 is not due to off-target effects. These results suggest that IPP5 is a negative regulator of neurite growth in primary sensory neurons.
The interaction with and inhibition of PP1 is responsible for the effect of IPP5 on neurite growth in cultured primary sensory neurons IPP5 has been identified as a novel inhibitory subunit of PP1 that contains both the PP1 docking motif and the PP1 inhibiting motif (Wang et al., 2008) . The PP1 docking motif " 8 KIQF 12 " is required for IPP5 binding to PP1, and the threonine at position 34 (Thr 34 ) within the PP1 inhibiting motif is presumed to bind to the active site of PP1 when phosphorylated (Svenningsson et al., 2004; Wang et al., 2008) . A co-immunoprecipitation (co-IP) experiment confirmed that IPP5 interacts with PP1 in both rat DRGs and HEK293T cells expressing IPP5 (Fig. 3B, C) . Consistent with the shRNA knockdown experiment, IPP5 overexpression in cultured rat DRG neurons (Supplementary Material, Fig. S2A , B) reduced the length of the longest neurite to approximately 63% of the control (Fig. 3D, E) , reduced the total neurite length to approximately 72% of the control (Fig. 3D, F) , and reduced the number of neurite ends to 84% of the control (Fig. 3D, G (Fig. 3C) . Correspondingly, IPP5-M had no significantly inhibitory effect on the length of the longest neurite, the total neurite length or the number of neurite ends ( Fig. 3D-G) . These data indicate that the interaction of IPP5 with PP1 is essential for its inhibition of neurite growth.
Previous in vitro protein phosphatase assays have shown that IPP5 phosphorylated at Thr 34 and IPP5 T34D (Fig. 3A) , a phosphorylation-mimicking mutant, were able to effectively inhibit PP1 activity with IC 50 values of 45 nM and 110 nM, respectively, while IPP5 T34A (Fig. 3A) , a phosphorylation-deficient mutant, had no effect on PP1 (Wang et al., 2008) . Our in vitro autoradiograph assay showed that IPP5 was phosphorylated by PKA but IPP5 T34D was not (Fig. 4A ). The phosphorylation of IPP5 was also detected by a site-specific monoclonal antibody against phosphorylated Thr 34 , which was blocked by the PKA pharmacological inhibitor H89 (Fig. 4B ).
Further pharmacological assays showed that the phosphorylation level of IPP5 at Thr 34 was dramatically elevated by treating cultured DRG neurons with the cAMP/PKA signaling pathway activator forskolin and was further enhanced by the protein phosphatase 2B (PP2B) inhibitor cyclosporin A (Fig. 4C) . Thus, Thr 34 within the PP1-inhibiting motif of IPP5 is phosphorylated by PKA and dephosphorylated by PP2B, similar to the other PPP1R1 family members, inhibitor-1 and DARPP-32 (Endo et al., 1996; Nairn et al., 2004; Weiser et al., 2004) .
To further investigate whether the regulation of neurite growth by IPP5 depends on its inhibition against PP1, dissociated DRG neurons were electroporated with IPP5 or its two phosphorylation mutants, IPP5 T34A and IPP5 T34D . Similar to the cultured DRG neurons expressing IPP5, the length of the longest neurite, the total neurite length and the number of neurite ends were markedly decreased in neurons expressing IPP5 T34D but not IPP5 T34A ( Fig. 4D-G) . Taken together, these data indicate that both the interaction with and inhibition of PP1 are indispensable for the negative regulation of neurite growth by IPP5.
IPP5 maintains TGF-β signaling
Given that PP1 mediates the effect of IPP5 on neurite growth in primary sensory neurons, we searched for the downstream pathway. Several signaling molecules have been reported to be both regulated by PP1 and involved in the regulation of neurite growth (Abe et al., 2010; Bito et al., 1996; Gao et al., 2004; Hur et al., 2011; Morfini et al., 2004; Shi et al., 2004; Stegmuller et al., 2008; Thayyullathil et al., 2011; Xiao et al., 2010; Zhou et al., 2004 (Fig. 5B ). This result suggests that IPP5 positively regulates the TGF-β/Smad signal pathway, and the interaction with and inhibition of PP1 are also essential for IPP5-mediated Smad2/3 activation.
We also tested whether IPP5 regulates the TGF-β signaling pathway in primary sensory neurons. Immunocytochemistry showed that IPP5 colocalized with PP1 and TβRI in the region near the plasma membrane in dissociated DRG neurons (Fig. 5C ).
After TGF-β1 stimulation, the distributions of IPP5, PP1 and TβRI were not 
IPP5 inhibits neurite growth by regulating the TGF-β signaling pathway
The TGF-β/Smad signaling pathway has been reported to be an intrinsic negative regulator of neurite growth (He and Wang, 2006; Hellal et al., 2011; Kohta et al., 2009; Ng, 2008; Stegmuller et al., 2008) . Considering the effect of IPP5 on TGF-β/Smad signaling, we investigated the involvement of the TGF-β/Smad pathway in the IPP5-induced inhibition of neurite growth. Reverse transcription PCR showed that TGF-β1, TGF-β2, and TGF-β3 were expressed in both DRGs and cultured DRG neurons (Supplementary Material, Fig. S4C ). We then performed neurite growth assays in the presence of TGF-βs. The data showed that the length of the longest neurite, the total neurite length and the number of neurite ends were dramatically inhibited by TGF-βs ( ( Fig. 6 ). Similarly, IPP5-M, which lacks the ability to bind PP1, did not enhance the TGF-β1-induced inhibition of neurite growth (Fig. 6 ). These data show that IPP5
enhances the TGF-β-induced inhibition of neurite growth in a PP1-dependent manner.
A drug (SB-431542) has been reported to be a potent and specific inhibitor of the TGF-β receptor superfamily. It dramatically inhibits the kinase activity of TβRI, the activin type I receptor and the nodal type I receptor, but it has little effect on other 
Discussion
IPP5 is a PP1-inhibiting protein that has been shown to regulate tumor cell cycle, growth and apoptosis (Wang et al., 2008; Zeng et al., 2009 ). Here, we report a critical role of IPP5 in the inhibition of neurite growth in primary sensory neurons. IPP5 was
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selectively expressed in the DRG in the nervous system, specifically in small primary sensory neurons. If the ability of IPP5 to interact with or inhibit PP1 was disrupted, the inhibitory effects of IPP5 on neurite growth were impaired. IPP5 formed a protein complex with TβRI and PP1 and maintained TGF-β/Smad signaling by inhibiting the function of PP1 (Fig. 8D) . Furthermore, IPP5 enhanced the TGF-β-induced inhibition of neurite growth. Blockage of TGF-β/Smad signaling disrupted the IPP5-induced inhibition of neurite growth. These findings extend our understanding about the function of the regulatory subunits of PP1 in the nervous system.
IPP5 inhibits neurite growth in primary sensory neurons in a PP1-dependent manner
Phosphorylation and dephosphorylation of cellular proteins by protein kinases and phosphatases are important mechanisms for controlling many cellular events. In the nervous system, protein phosphatases are contained in highly dynamic complexes localized within specialized subcellular compartments to ensure the temporally and spatially controlled dephosphorylation of multiple neuronal phosphoproteins (Mansuy and Shenolikar, 2006) . Approximately ten different regulatory subunits of PP1 have been identified in the nervous system (Cohen, 2002) . Neurabin-I and spinophilin are both regulatory subunits targeting PP1 to F-actin during neuronal development, which regulates spine development or axonal growth by affecting the cytoskeletal dynamics in hippocampal and cortical neurons (Bielas et al., 2007; Oliver et al., 2002 
The TGF-β/Smad signaling pathway mediates the IPP5-induced inhibition of neurite growth
Regulatory subunits endow PP1 with distinct substrate specificities and restricted subcellular locations (Cohen, 2002) . It is important to identify the phosphoprotein substrates of the IPP5-PP1 holoenzyme complex. The phosphorylation levels of CREB, Akt and GSK3β were not altered in cells expressing IPP5 and its mutants.
Importantly, in HEK293T cells expressing IPP5 or IPP5 T34D , the phosphorylation level of Smad2/3 was significantly elevated after TGF-β stimulation. In cultured DRG neurons, the TGF-β-induced phosphorylation of Smad2/3 was reduced after knocking down IPP5. Thus, IPP5 positively regulates TGF-β/Smad signaling. PP1 has been shown to dephosphorylate activated TβRI but not Smad2/3, which is an effective negative feedback mechanism for regulating TGF-β/Smad signaling (Lin et al., 2006; Shi et al., 2004) . IPP5, TβRI and PP1 were found to colocalize in the region near the plasma membrane in dissociated DRG neurons. Importantly, IPP5 was shown to interact with TβRI and PP1, which formed a complex in DRG neurons. In HEK293T
Journal of Cell Science Accepted manuscript cells expressing the IPP5 mutants that lack PP1 binding or inhibiting activities, the phosphorylation levels of Smad2/3 were not further elevated after TGF-β stimulation.
These data suggest a model in which IPP5 inhibits PP1 activity, keeps TβRI activity, and maintains TGF-β/Smad signaling (Fig. 8D) .
During the development of the nervous system, TGF-β/Smad signaling is critical for establishing neuronal polarity and axonal identity (Awasaki et al., 2011; Farkas et al., 2003; Ng, 2008; Stegmuller et al., 2008; Yi et al., 2010) . 
Functional implications of IPP5 in vivo
In this study, IPP5 was found to be highly expressed in the peripheral nervous system but not in the central nervous system, including the cortex, cerebellum, hypothalamus, After nerve injury, IPP5 in the DRG is remarkably downregulated, indicating the activation of a mechanism to increase the intrinsic capacity for neurite growth in primary sensory neurons. Interestingly, IPP5 is dominantly expressed in small primary sensory neurons. Other inhibitory subunits expressed in large primary sensory neurons may also regulate PP1 function.
Materials and Methods
Plasmid construction
The expression construct of IPP5 was generated by inserting coding sequence of the 
Journal of Cell Science Accepted manuscript
of a peripheral nerve injury, a 5 mm portion of rat sciatic nerve was transected at mid-thigh level. The rats were allowed to survive for 2, 7, 14 or 28 days (10 rats for each time point).
PCR
Total RNA was isolated from the tissues of adult rats using TRIzol reagent (Invitrogen, Carlsbad, CA). The first-strand cDNA was generated using SuperScript®II Reverse Transcriptase (Invitrogen) for reverse transcription PCR, and the products were analyzed on a 1% agarose gel. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as an internal control. The real-time PCR was performed in triplicate with SYBR Premix Ex Taq (TaKaRa, Shiga, Japan) on an ABI 7500 real-time PCR system (Applied Biosystems, Carlsbad, CA), and the endogenous mRNA values of IPP5 were normalized to that of GAPDH. The primers were as follows: 5'-cctacaccagcatcccttgt-3' and 5'-ttgcgctttcttcttcttcc-3' for IPP5;
5'-aagaacctgagggagccact-3' and 5'-tgggaatccagtggtagcat-3' for Inhibitor-1;
5'-cacccaaagtcgaagagacc-3' and 5'-tcatcctcgtcctcatcctc-3' for DARPP-32; and 5'-ggcaagttcaacggcacag-3' and 5'-cgccagtagactccacgac-3' for GAPDH.
Immunohistochemistry and immunocytochemistry
Adult rats were anesthetized and perfused through the ascending aorta with saline were cultured in DMEM (Invitrogen) with 10% fetal bovine serum, 100 U/ml penicillin / 100 pg/ml streptomycin mixture, and 2 mM L-glutamine (Invitrogen). 
Immunoprecipitation and immunoblotting
Freshly isolated DRGs from adult rats or dissociated DRG neurons or transfected HEK293T cells were lysed in ice-cold immunoprecipitation buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100 and 10% glycerol). The lysate was immunoprecipitated with 0.5 µg of a mouse antibody against IPP5 or HA tag Phosphorylation status was analyzed by SDS-PAGE and immunoblotting.
Statistical analyses
The data are shown as the mean ± s.e.m. Statistical significance was calculated using unpaired or paired Student's t-tests. The Kolmogorov-Smirnov test (KS-test) was performed to determine the significance between two groups for the cumulative frequency of the length of the longest neurite, the total neurite length and the number of neurite ends. Differences were considered significant at P<0.05.
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